The Mantoux test, also known as the tuberculin skin test, is a diagnostic tool used to detect the presence of tuberculosis infection in individuals. It helps identify those who may require further evaluation or treatment.
Tuberculosis is primarily transmitted through the air when an infected individual coughs, sneezes, or talks, releasing tiny droplets containing the Mycobacterium tuberculosis bacteria.
The Mantoux test plays a critical role in tuberculosis screening and prevention strategies. By identifying individuals with latent tuberculosis infection, we can initiate appropriate treatment and prevent the development of active TB disease.
The test involves injecting a small amount of purified protein derivative (PPD) under the skin. After 48 to 72 hours, the test site is examined for a reaction, which helps determine the presence of tuberculosis infection.
The test result is measured by the size of the induration (raised area) at the test site. A positive result indicates exposure to TB bacteria, but additional tests may be required to confirm active disease.
A positive Mantoux test indicates latent tuberculosis infection, where the bacteria remain inactive in the body. Early identification of LTBI helps prevent the progression to active tuberculosis.
The Mantoux test is generally safe, with minimal risks of complications. It may cause a small, temporary bump or redness at the injection site. Inform your healthcare provider of any known allergies or medical conditions.
£90 each
Find out what vaccines you need for your destination and book your appointment now.